Nasdaq, Inc. will delist stocks and warrants from several companies including Digital Brands Group and Lipella Pharmaceuticals as part of its strategy to streamline its market offerings. Simultaneously, Nasdaq is enhancing its partnership with AWS to deliver high-performing infrastructure solutions, aligning with its ambitious financial growth projections. Despite a substantial short interest totaling over 17 billion shares, Nasdaq anticipates a 27.8% year-over-year increase in cash flow and earnings of $2 billion by 2028, showcasing its resilience in a challenging market.
“Nasdaq and AWS · enhance · Nasdaq Calypso’s solution · high-performing, scalable and secure infrastructure”
“Nasdaq and AWS · are partners in · strategic technology · expansion”
“Nasdaq · is used by · 97% of global systematically important banks · true”
“Nasdaq · serves · 3,800+ clients across the financial services industry · true”
“short interest in 3,341 Nasdaq Global Market securities · totaled · shares · 14,035,983,054”
“short interest in 1,673 securities on The Nasdaq Capital Market · totaled · shares · 3,110,176,592”
“short interest in all 5,014 Nasdaq securities · totaled · shares · 17,146,159,646”
“Nasdaq Global Market · total short interest shares · 3,341 securities · 14,035,983,054”
“The Nasdaq Capital Market · total short interest shares · 1,673 securities · 3,110,176,592”
“Nasdaq, Inc. · will delist · the warrants of Digital Brands Group, Inc. · true”
“Nasdaq, Inc. · will delist · the common stock of Lipella Pharmaceuticals Inc. · true”
“Nasdaq, Inc. · will delist · the common stock of ZyVersa Therapeutics, Inc. · true”